Described herein are materials and methods for using a HER3 binding agent for prostate treatment. The HER3 binding agent can be, for example, an antibody, and can be used to treat conditions such as benign prostate hyperplasia (BPH) and prostate cancer.
申请公布号
WO2012018404(A2)
申请公布日期
2012.02.09
申请号
WO2011US01400
申请日期
2011.08.08
申请人
U3 PHARMA GMBH;AMGEN;HETTMANN, THORE;FREEMAN, DANIEL, J.;RADINSKY, ROBERT;BEAUPRE, DARRIN, M.
发明人
HETTMANN, THORE;FREEMAN, DANIEL, J.;RADINSKY, ROBERT;BEAUPRE, DARRIN, M.